Kayla Rosati

Tufts Medical CenterBoston, Massachusetts - 02111 (617-636-5322) |
- CLINICAL TRIALS 1
- CONDITIONS5
- INTERVENTIONS1
- SINCE2009

Study Safety and Preliminary Efficacy of DCC-2036 in Patients With Leukemias
March 2009 - April 2011
Leukemia
Leukemia, Lymphoid
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Leukemia, Myeloid
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Dcc-2036



